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Inherited factors contribute to the lifetime risk of prostate
cancer. These factors include a positive family history of
cancer and a mutation in one of several prostate cancer
susceptibility genes, A number of genome-wide association
studies (GWAS) have identified over a number of single
nucleotide polymorphisms that have been confirmed to be
associated with prostate cancer risk We evaluated whether
or not genotyping of 18 different prostate cancer founder
alleles in the Polish population is helpful in identifying
high-risk individuals and for determining optimal screen-
ing regimens. A serum PSA level was measured and a digi-
tal rectal examination was performed on 2907 unaffected
men aged 40-90. All men were genotyped for three foun-
der alleles in BRCA1 (5382insC, 4153delA, C61G), four
alleles in CHEK2 (1100delC, IVS2+1G>A, del5395, I157T),
one allele in NBS1 (657del5), one allele in HOXB13
(G84E), and for nine SNPs which have previously been
shown to be associated with prostate cancer risk. A foun-
der mutation in CHEK2 (I157T) predicted prostate cancer
in unscreened men.
Published: 10 December 2012
doi:10.1186/1897-4287-10-S4-A28
Cite this article as: Cybulski et al.: Prostate cancer screening based on
genotyping for high risk founder alleles. Hereditary Cancer in Clinical
Practice 2012 10(Suppl 4):A28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitDepartment of Genetics and Pathomorphology of the Pomeranian Medical
University, Szczecin, Poland
Cybulski et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A28
http://www.hccpjournal.com/content/10/S4/A28
© 2012 Cybulski et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
